Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
Clinical trial NCT02741128 · COMPLETED
Trial details
- NCT number
- NCT02741128
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2023-01-19
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.